(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

NCT05907954 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Uveal Melanoma

Interventions

DRUG: Darovasertib

Sponsor

IDEAYA Biosciences